Researchers have been excited about the medication , a novel dual agonist showing remarkable results in early trials for weight loss . It functions by modulating two pathways : GLP-1 and GIP, which , when https://jasonxbpg729368.blogdon.net/the-new-prospect-for-weight-reduction-56898678